Falcon Point Capital’s Integra LifeSciences IART Stock Holding History

Falcon Point Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-22,097	Closed	-$1.23M	–	113
2019 Q2	$1.23M	Sell	22,097 -58,632	-73%	-$3.02M	0.66%	44
2019 Q1	$4.5M	Sell	80,729 -3,526	-4%	-$180K	2.45%	12
2018 Q4	$3.8M	Sell	84,255 -116,720	-58%	-$6.4M	2.27%	15
2018 Q3	$13.2M	Buy	200,975 +50,553	+34%	+$3.14M	2.84%	5
2018 Q2	$9.69M	Sell	150,422 -67,842	-31%	-$4.2M	1.9%	22
2018 Q1	$12.1M	Sell	218,264 -40,399	-16%	-$2.12M	2.41%	12
2017 Q4	$12.4M	Buy	258,663 +3,456	+1%	+$169K	2.09%	21
2017 Q3	$11.9M	Buy	255,207 +62,483	+32%	+$3.21M	1.73%	26
2017 Q2	$10.5M	Sell	192,724 -164,317	-46%	-$7.85M	1.42%	33
2017 Q1	$15M	Sell	357,041 -4,119	-1%	-$176K	2.01%	20
2016 Q4	$15.5M	Buy	361,160 +26,868	+8%	+$1.09M	2.08%	21
2016 Q3	$13.3M	Buy	334,292 +65,706	+24%	+$2.75M	2.03%	24
2016 Q2	$10.7M	Buy	268,586 +15,868	+6%	+$571K	1.85%	24
2016 Q1	$8.51M	Buy	252,718 +74,196	+42%	+$2.31M	1.47%	35
2015 Q4	$6.05M	Buy	+178,522	New	+$5.58M	1.31%	40

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Falcon Point Capital's IART Position: Q3 2019 in Review

Falcon Point Capital sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 22,097 shares — an estimated $1.23M sold.

Falcon Point Capital first reported a position in IART in Q4 2015 and held it in 15 quarters. The position peaked at $15.5M in Q4 2016. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Falcon Point Capital reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
Falcon Point Capital sold 22,097 Integra LifeSciences shares in Q3 2019, an estimated $1.23M.
Falcon Point Capital first reported a position in Integra LifeSciences in Q4 2015 and held it in 15 quarters.
Falcon Point Capital's Integra LifeSciences position peaked at $15.5M in Q4 2016.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Falcon Point Capital's 13F filing for Q3 2019, filed 13 Nov 2019.